Subcutaneous fat localization -
Cellulite does not disappear completely with sport and diet. Burning subcutaneous fat with exercise helps to reduce the size of it and, more importantly, to prevent it from getting worse.
Nevertheless, to even the skin texture and improve orange-peel skin, you need to use a specific treatment that helps you dissolve and shrink those enlarged adipocytes and restore the atrophied septae.
Body Contour is part of the INNO-EPIGEN® range of products whose main distinctive feature is the use of epigenetic active ingredients to improve skin health and condition.
Epigenetics is a branch of science that studies how the expression of genes affects our health and function. All INNO-EPIGEN® products include epigenetic active ingredients that help to modulate the expression of those genes involved in skin-aging and the development of skin problems.
This particularity makes all the products in the range very effective when it comes to solving the lack of skin proteins, improving skin balance, and slowing down skin aging. It is a body contouring cream that visibly improves the appearance of cellulite and localized fat.
This formula will help you dissolve the excess of adipocytes in the subcutaneous fat deposits, as it promotes lipolysis and the elimination of toxins. The action of the epigenetic ingredients contained in it improve skin blood flow, and favor the formation of collagen and elastin , helping to restore the connective tissue.
Moreover, it boosts skin firmness, elasticity, and moisture. Some of the key ingredients in the formula are DMAE, Carnitine, Caffeine, Glutrapeptide, Capsaicin, Maslinic Acid, and our exclusive Smart GPS®.
PREPARE YOUR BODY FOR GOING OUT AFTER LOCKDOWN WITH INNO-EPIGEN® BODY CONTOUR This historic moment we are living in is teaching most of us a lot about ourselves and our closest ones.
It is a multifactorial skin problem, commonly triggered by: Genetic predisposition. Hormonal changes, being the decrease of estrogen the most significant. Gain of weight contributes to the enlargement of adipocytes. Poor circulation, as it leads to lower collagen production in the fibrous connective tissue.
Poor lymphatic drainage. Alcohol, cigarettes, and a sedentary lifestyle can worsen it. WHY INNO-EPIGEN® BODY CONTOUR OFFERS A DIFFERENT APPROACH? INNO-EPIGEN® BODY CONTOUR It is a body contouring cream that visibly improves the appearance of cellulite and localized fat.
Benefits: Helps to even skin texture. Reduces localized fat and dimpled skin. Tones up and firms the skin. Improves elasticity and moisture. Applying it day and night, you will notice improvement within ten days.
Search Search for:. Categories Advices The Expert´s Opinion Uncategorized. This website uses cookies to improve the browsing experience. You can review the cookies and set their configuration at Cookie Settings ACCEPT REJECT. Close Privacy Overview This website uses cookies to improve your experience while you navigate through the website.
Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website.
These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Data Privacy Policy Cookie Policy. Necessary Necessary. Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Anderson PJ, Chan JC, Chan YL, Tomlinson B, Young RP, Lee ZS, et al. Visceral fat and cardiovascular risk factors in Chinese NIDDM patients. Diabetes Care. Després JP.
Body fat distribution and risk of cardiovascular disease an update. Sironi AM, Petz R, De Marchi D, Buzzigoli E, Ciociaro D, Positano V, et al. Impact of increased visceral and cardiac fat on cardiometabolic risk and disease.
Diabet Med. St St-Pierre J, Lemieux I, Vohl MC, Perron P, Tremblay G, Després JP, et al. Contribution of abdominal obesity and hypertriglyceridemia to impaired fasting glucose and coronary artery disease. Am J Cardiol. Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss.
J Am Coll Cardiol. Klöting N, Blüher M. Adipocyte dysfunction, inflammation and metabolic syndrome. Rev Endocr Metab Disord.
Tarui S, Tokunaga K, Fujioka S, Matsuzawa Y. Visceral fat obesity: anthropological and pathophysiological aspects. Int J Obes. PubMed Google Scholar. Capeau J. Insulin resistance and steatosis in humans. Diabetes Metab. Kotronen A, Yki-Jarvinen H.
Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol. Abdulkadirova FR, Ametov AS, Doskina EV, Pokrovskaya RA.
The role of the lipotoxicity in the pathogenesis of type 2 diabetes mellitus and obesity. Obes Metab. Sung KC, Wild SH, Kwag HJ, Byrne CD. Fatty liver, insulin resistance, and features of metabolic syndrome: relationships with coronary artery calcium in 10, people. Gastaldelli A, Cusi K, Pettiti M, Hardies J, Miyazaki Y, Berria R, et al.
Targher G, Zoppini G, Day CP. Risk of all-cause and cardiovascular mortality in patients with chronic liver disease.
author reply —4. Kozakova M, Palombo C, Eng MP, Dekker J, Flyvbjerg A, Mitrakou A, et al. Fatty liver index, gamma-glutamyltransferase, and early carotid plaques. Bonapace S, Perseghin G, Molon G, Canali G, Bertolini L, Zoppini G, et al. Nonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in patients with type 2 diabetes.
Assy N, Djibre A, Farah R, Grosovski M, Marmor A. Presence of coronary plaques in patients with nonalcoholic fatty liver disease. Pezeshkian M, Noori M, Najjarpour-Jabbari H, Abolfathi A, Darabi M, Darabi M, et al. Fatty acid composition of epicardial and subcutaneous human adipose tissue.
Metab Syndr Relat Disord. Iacobellis G, Corradi D, Sharma AM. Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med. Löhn M, Dubrovska G, Lauterbach B, Luft FC, Gollasch M, Sharma AM. Periadventitial fat releases a vascular relaxing factor.
FASEB J. Yamaguchi Y, Cavallero S, Patterson M, Shen H, Xu J, Kumar SR, et al. Adipogenesis and epicardial adipose tissue: a novel fate of the epicardium induced by mesenchymal transformation and PPARγ activation.
Proc Natl Acad Sci U S A. Manzella D, Barbieri M, Rizzo MR, Ragno E, Passariello N, Gambardella A, et al. Role of free fatty acids on cardiac autonomic nervous system in noninsulin-dependent diabetic patients: effects of metabolic control.
J Clin Endocrinol Metab. Mahabadi AA, Massaro JM, Rosito GA, Levy D, Murabito JM, Wolf PA, et al. Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: the Framingham heart study.
Eur Heart J. Corradi D, Maestri R, Callegari S, Pastori P, Goldoni M, Luong TV, et al. The ventricular epicardial fat is related to the myocardial mass in normal, ischemic and hypertrophic hearts. Cardiovasc Pathol. Eroglu S, Sade LE, Yildirir A, Bal U, Ozbicer S, Ozgul AS, et al.
Epicardial adipose tissue thickness by echocardiography is a marker for the presence and severity of coronary artery disease. Nutr Metab Cardiovasc Dis. Wang CP, Hsu HL, Hung WC, Yu TH, Chen YH, Chiu CA, et al. Increased epicardial adipose tissue EAT volume in type 2 diabetes mellitus and association with metabolic syndrome and severity of coronary atherosclerosis.
Clin Endocrinol. Romantsova TI, Ovsyannikovna AV. Perivascular adipose tissue: role in the pathogenesis of obesity, type 2 diabetes mellitus and cardiovascular pathology. Frontini A, Rousset S, Cassard-Doulcier AM, Zingaretti C, Ricquier D, Cinti S. Thymus uncoupling protein 1 is exclusive to typical brown adipocytes and is not found in thymocytes.
J Histochem Cytochem. Sacks HS, Fain JN, Holman B, Cheema P, Chary A, Parks F, et al. Uncoupling protein-1 and related messenger ribonucleic acids in human epicardial and other adipose tissues: epicardial fat functioning as brown fat.
Chatterjee TK, Stoll LL, Denning GM, Harrelson A, Blomkalns AL, Idelman G, et al. Proinflammatory phenotype of perivascular adipocytes: influence of high-fat feeding. Circ Res. Li T, Liu X, Ni L, Wang Z, Wang W, Shi T, et al. Perivascular adipose tissue alleviates inflammatory factors and stenosis in diabetic blood vessels.
Biochem Biophys Res Commun. Schlett CL, Massaro JM, Lehman SJ, Bamberg F, O'Donnell CJ, Fox CS, et al. Novel measurements of periaortic adipose tissue in comparison to anthropometric measures of obesity, and abdominal adipose tissue. Rittig K, Staib K, Machann J, Böttcher M, Peter A, Schick F, et al.
Perivascular fatty tissue at the brachial artery is linked to insulin resistance but not to local endothelial dysfunction. Lehman SJ, Massaro JM, Schlett CL, O'Donnell CJ, Hoffmann U, Fox CS.
Peri-aortic fat, cardiovascular disease risk factors, and aortic calcification: the Framingham heart study. Pfeifer A, Hoffmann LS. Brown, beige, and white: the new color code of fat and its pharmacological implications. Annu Rev Pharmacol Toxicol.
Rosenwald M, Perdikari A, Rülicke T, Wolfrum C. Bi-directional interconversion of brite and white adipocytes. Nat Cell Biol. Omar A, Chatterjee TK, Tang YL, Hui DY, Weintraub NL. Proinflammatory phenotype of perivascular adipocytes. Zhang H, Park Y, Wu J, Chen X, Lee S, Yang J, et al.
Role of TNF-alpha in vascular dysfunction. Clin Sci Lond. Download references. Federal State Budgetary Institution, Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo, Russian Federation.
Federal State Budget Educational Institution of Higher Education, Kemerovo State Medical University of the Ministry of Healthcare of the Russian Federation, Kemerovo, Russian Federation.
Autonomous Public Healthcare Institution of the Kemrovo Region, Kemerovo Regional Clinical Hospital named after S. Beliyaev, Regional Center for Diabetes, Kemerovo, Russian Federation.
You can also search for this author in PubMed Google Scholar. OG and OB wrote and revised the manuscript, DB and YD collected and reviewed the literature. All authors read and approved the final manuscript. Correspondence to Evgenya Uchasova.
The Ethics Committee of the Federal State Budgetary Institution, Research Institute for Complex Issues of Cardiovascular Diseases approved this study protocol No. Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open Access This article is distributed under the terms of the Creative Commons Attribution 4. Reprints and permissions. Gruzdeva, O. et al. Localization of fat depots and cardiovascular risk. Lipids Health Dis 17 , Download citation. Received : 12 June Accepted : 28 August Published : 15 September Anyone you share the following link with will be able to read this content:.
Sorry, a shareable link is not currently available for this article. Provided by the Springer Nature SharedIt content-sharing initiative.
Skip to main content. Search all BMC articles Search. Download PDF. Abstract Despite the existing preventative and therapeutic measures, cardiovascular diseases remain the main cause of temporary disability, long-term disability, and mortality.
Background Despite the existing preventative and therapeutic measures, cardiovascular diseases CVD remain the main cause of temporary disability and mortality [ 1 ].
Table 1 The relationship between various depots of fat and cardiovascular diseases Full size table. Conclusion It is known that each local fat depot can be considered an independent endocrine organ that actively produces biologically active molecules, such as pro- and anti-inflammatory cytokines and adipokines.
Mechanisms of various ectopic fats related with cardiovascular deseases. Full size image. Abbreviations BMI: Body mass index CAD: Coronary artery disease CT: Computed tomography CVD: Cardiovascular diseases EAT: Epicardial adipose tissue FFA: Free fatty acids IR: Insulin resistance MS: Metabolic syndrome NAFLD: Non-alcoholic fatty liver disease NASH: Alcoholic steatohepatitis PVAT: Perivascular adipose tissue SAT: Subcutaneous adipose tissue VAT: Visceral adipose tissue VO: Visceral obesity.
References Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Article Google Scholar Roth GA, Forouzanfar MH, Moran AE, Barber R, Nguyen G, Feigin VL, et al.
Article CAS Google Scholar Lainscak M, Blue L, Clark AL, Dahlström U, Dickstein K, Ekman I, et al. Article Google Scholar Pereira PF, Serrano HM, Carvalho GQ, Lamounier JA, Peluzio Mdo C, Franceschini Sdo C, et al.
Article Google Scholar Barquera S, Pedroza-Tobías A, Medina C, Hernández-Barrera L, Bibbins-Domingo K, Lozano R, et al. Article Google Scholar Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE, et al. Article CAS Google Scholar Artinian NT, Fletcher GF, Mozaffarian D, Kris-Etherton P, Van Horn L, Lichtenstein AH, et al.
Article Google Scholar Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH. Article Google Scholar Kulikov VA. In Russian Google Scholar Brauer P, Connor Gorber S, Shaw E, Singh H, Bell N, Shane AR, et al. Article Google Scholar World Health Organization. Google Scholar Holley TJ, Collins CE, Morgan PJ, Callister R, Hutchesson MJ.
Article Google Scholar Ohlson LO, Larsson B, Svärdsudd K, Welin L, Eriksson H, Wilhelmsen L, et al. Article CAS Google Scholar Messier V, Karelis AD, Prud'homme D, Primeau V, Brochu M, Rabasa-Lhoret R. Article Google Scholar Britton KA, Fox CS. Article Google Scholar Lima MM, Pareja JC, Alegre SM, Geloneze SR, Kahn SE, Astiarraga BD, et al.
Article Google Scholar Han E, Lee YH, Lee BW, Kang ES, Lee IK, Cha BS. Article Google Scholar Fujioka S, Matsuzawa Y, Tokunaga K, Tarui S. Article CAS Google Scholar Sjöström L, Kvist H, Cederblad A, Tylén U.
Google Scholar Veilleux A, Côté JA, Blouin K, Nadeau M, Pelletier M, Marceau P, et al. Article Google Scholar Ashwell M. Article Google Scholar Silva AA, Carmo JM, Dubinion J, et al.
Article Google Scholar Odegaard JI, Chawla A. Article CAS Google Scholar Kovalik JP, Slentz D, Stevens RD, Kraus WE, Houmard JA, Nicoll JB, et al. Article CAS Google Scholar Litvinova LS, Vasilenko MA, Zatolokin PA, Aksenova NN, Fattakhov NS, Vaysbeyn IZ, et al.
In Russian Google Scholar Könner AC, Brüning JC. Article Google Scholar Ott AV, Chumakova GA, Veselovskaya NG. In Russian Article Google Scholar Gruzdeva O, Uchasova E, Dyleva Y, Borodkina D, Akbasheva O, Belik E, et al.
Article Google Scholar Anderson PJ, Chan JC, Chan YL, Tomlinson B, Young RP, Lee ZS, et al. Article CAS Google Scholar Després JP. Article Google Scholar Sironi AM, Petz R, De Marchi D, Buzzigoli E, Ciociaro D, Positano V, et al. Article CAS Google Scholar St St-Pierre J, Lemieux I, Vohl MC, Perron P, Tremblay G, Després JP, et al.
Article Google Scholar Lavie CJ, Milani RV, Ventura HO. Article Google Scholar Klöting N, Blüher M. Article Google Scholar Tarui S, Tokunaga K, Fujioka S, Matsuzawa Y. PubMed Google Scholar Capeau J. Article CAS Google Scholar Kotronen A, Yki-Jarvinen H. Article CAS Google Scholar Abdulkadirova FR, Ametov AS, Doskina EV, Pokrovskaya RA.
In Russian Article Google Scholar Sung KC, Wild SH, Kwag HJ, Byrne CD. Article CAS Google Scholar Gastaldelli A, Cusi K, Pettiti M, Hardies J, Miyazaki Y, Berria R, et al. Article CAS Google Scholar Targher G, Zoppini G, Day CP. author reply —4 Article Google Scholar Kozakova M, Palombo C, Eng MP, Dekker J, Flyvbjerg A, Mitrakou A, et al.
Article CAS Google Scholar Bonapace S, Perseghin G, Molon G, Canali G, Bertolini L, Zoppini G, et al. Article CAS Google Scholar Assy N, Djibre A, Farah R, Grosovski M, Marmor A. Article Google Scholar Pezeshkian M, Noori M, Najjarpour-Jabbari H, Abolfathi A, Darabi M, Darabi M, et al. Article CAS Google Scholar Iacobellis G, Corradi D, Sharma AM.
Article Google Scholar Löhn M, Dubrovska G, Lauterbach B, Luft FC, Gollasch M, Sharma AM. Article Google Scholar Yamaguchi Y, Cavallero S, Patterson M, Shen H, Xu J, Kumar SR, et al.
Article CAS Google Scholar Manzella D, Barbieri M, Rizzo MR, Ragno E, Passariello N, Gambardella A, et al. Article CAS Google Scholar Mahabadi AA, Massaro JM, Rosito GA, Levy D, Murabito JM, Wolf PA, et al.
Article Google Scholar Corradi D, Maestri R, Callegari S, Pastori P, Goldoni M, Luong TV, et al. Article Google Scholar Eroglu S, Sade LE, Yildirir A, Bal U, Ozbicer S, Ozgul AS, et al.
Article CAS Google Scholar Wang CP, Hsu HL, Hung WC, Yu TH, Chen YH, Chiu CA, et al. Article Google Scholar Romantsova TI, Ovsyannikovna AV. In Russian Article Google Scholar Frontini A, Rousset S, Cassard-Doulcier AM, Zingaretti C, Ricquier D, Cinti S.
Article CAS Google Scholar Sacks HS, Fain JN, Holman B, Cheema P, Chary A, Parks F, et al. Article CAS Google Scholar Chatterjee TK, Stoll LL, Denning GM, Harrelson A, Blomkalns AL, Idelman G, et al. Article CAS Google Scholar Li T, Liu X, Ni L, Wang Z, Wang W, Shi T, et al.
Article CAS Google Scholar Schlett CL, Massaro JM, Lehman SJ, Bamberg F, O'Donnell CJ, Fox CS, et al. Article CAS Google Scholar Rittig K, Staib K, Machann J, Böttcher M, Peter A, Schick F, et al. Article CAS Google Scholar Lehman SJ, Massaro JM, Schlett CL, O'Donnell CJ, Hoffmann U, Fox CS.
Article CAS Google Scholar Pfeifer A, Hoffmann LS. Article CAS Google Scholar Rosenwald M, Perdikari A, Rülicke T, Wolfrum C. Article CAS Google Scholar Omar A, Chatterjee TK, Tang YL, Hui DY, Weintraub NL.
Article CAS Google Scholar Zhang H, Park Y, Wu J, Chen X, Lee S, Yang J, et al. Article CAS Google Scholar Download references. Funding The study was supported by the Russian Science Foundation 17—
It is well-established that adipose Subcutaneouss accumulation is Subcutnaeous with insulin resistance through multiple loccalization. One Subcutaneoua metabolic Subcutaneous fat localization is the classical Randle cycle: Diabetic nephropathy screening Subcutaneous fat localization Subchtaneous Subcutaneous fat localization fatty acids FFA from hydrolysis of adipose far triglycerides impedes insulin-mediated glucose uptake in muscle tissues. Less well studied are the different routes of this communication. First, white adipose tissue depots may be regionally distant from muscle i. In this case, released FFA outflow through the venous drainage and merge into arterial plasma to be transported to muscle tissues. Next, cytosolic triglycerides can directly, i. Finally, adipocyte layers or lumps may be adjacent to, but not anatomically segregated, from muscle, as is typically the case for epicardial fat and cardiomyocytes. Klein MD. PART IV: Fundamental Aspects of Tumescent Gat Chapter Subcutaneous Subcutaneous fat localization Anatomy Avoidant/restrictive food intake disorder Histology. Subcutaneous fat localization gross anatomy Subvutaneous subcutaneous fat loca,ization not been well studied. Anatomists Subcutaneous fat localization traditionally regarded subcutaneous tissue as a mere envelope that contains more important structures. Except for an occasional reference to epidural, periorbital, perirenal, buccal, infrapatellar, ischiorectal, and retropubic fat, the gross anatomy of fat is rarely considered. Histology texts describe the individual cellular components of adipose fat tissue, but the overall architectural interrelationships among these components are seldom discussed. On initial inspection the structure of adipose tissue appears to be a random array of coalescing septa partitions.
0 thoughts on “Subcutaneous fat localization”